Texas Instruments' Stock Rises 7% On Earnings Beat
Date
4/24/2024 8:17:44 AM
(MENAFN- Baystreet) Visa's earnings Beat Forecasts On Strong Consumer Spending
Tesla Posts Biggest Revenue Decline Since 2012, Announces 'Affordable' EV
Rigetti Ekes up on Novera QPU Sale
Rigetti Ekes up on Novera QPU Sale
GE Aerospace Beats On Q1
profit And Raises Guidance Previous Articles Subscribe to Get Small Cap News & Alerts Baystreet Staff - Wednesday, April 24, 2024
Texas Instruments' Stock Rises 7% On Earnings Beat The stock of Texas Instruments (TXN) is up 7% after the legacy semiconductor company reported better-than-expected
financial results for this year's first quarter.
For Q1, Texas Instruments reported earnings per share $1.20 U.S., down 35% from a year ago but ahead of Wall Street forecasts of $1.07 U.S.
Revenue during the first three months of the year came in at $3.66 billion U.S., down 16% from a year ago, but also ahead of analyst estimates of $3.60 billion U.S.
While the earnings beat has Texas Instruments' stock marching higher, the company warned that it expects a recent pattern of weak microchip and semiconductor demand to continue in the current second quarter of the year.
Texas Instruments primarily makes chips and semiconductors for use in the automotive industry and industrial applications.
In terms of guidance, Texas Instruments sees Q2 revenue of $3.65 billion U.S. to $3.95 billion U.S., and profits of $1.05 U.S. to $1.25 U.S. per share.
The Q2 guidance aligns with Wall Street forecasts.
Prior to today (April 24), the stock of Texas Instruments had declined 6% over the last 12 months to trade at $165.47 U.S. per share.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN24042024000212011056ID1108132839
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.